GLP-1 Weight Loss Medications

• Commonly known as semaglutide and tirzepatide

• FDA approved for the treatment of obesity, Type 2 diabetes, sleep apnea, and heart disease.

• Regulates appetite

• Stabilizes glucose levels

• Aids with metabolism of protein, carbs, and fats

• Emerging evidence with potential benefits in treating PCOS (polycystic ovarian syndrome), NASH (Non Alcoholic Fatty Liver Disease), substance use disorders, autoimmune disorders (reduce inflammation levels).

 

 

Resources/studies to discover more about 

• Tirzepatide  (mounjaro/zepbound)
• Zepbound for sleep apnea and obesity
• Mounjaro for type 2 diabetes
• Wegovy for heart disease
• Ozempic for type 2 diabetes

Resources to discover more about semaglutide (labeled such as Ozempic):

• FDA
• Mayo Clinic
• UCLA Health
• Medline Plus

 

Refer to FAQ section for additional research studies